Content about sumatriptan

February 24, 2011
Par sees sales gains across all sectors

Generic drug maker Par Pharmaceutical Cos. had sales of $227 million during fourth quarter 2010 and $1 billion for the year as a whole, according to an earnings statement Thursday.

February 3, 2011
US WorldMeds introduces Alsuma

US WorldMeds has announced a new treatment for migraines, the drug maker said Wednesday.

August 1, 2010
Sagent's generic Imitrex receives regulatory approval

The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals...

March 9, 2010
Decision Resources: Acute migraine therapy designed for vascular disease patients will capture market share

A company that develops a drug for acute migraines in pill form that doesn’t interact...

January 11, 2009
Par reports Q1 results, enters partnership to develop Zetia generic

Par Pharmaceutical Cos. had total sales of $291.9 million and $26.3 million in profit for...

© 2013 Drug Store News. All Rights Reserved.